Cortechs.ai, ALZ-NET Partner to Advance Alzheimer’s Care with AI

Cortechs.ai, a global leader in AI-driven neuroimaging solutions, announced a strategic collaboration with the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) to enhance the quality of care for people living with Alzheimer’s disease. This collaboration brings together Cortechs.ai’s advanced imaging platform, NeuroQuant for ARIA, with ALZ-NET’s robust real-world data network to help inform clinical decision-making, improve care delivery and contribute to future treatment guidelines. As part of the collaboration, discounted access to NeuroQuant for ARIA will be offered to ALZ-NET sites across diverse clinical settings.

Cortechs.ai’s NeuroQuant for ARIA offers precise segmentation, quantification, and longitudinal tracking of both FLAIR and T2GRE/SWI lesions. This advanced functionality offers assistance with the surveillance of amyloid-related imaging abnormalities, such as ARIA-E and ARIA-H, in patients receiving anti-amyloid therapies. NeuroQuant for ARIA is validated on both 2D and 3D FLAIR sequences, ensuring compatibility with a broad range of imaging protocols. NeuroQuant for ARIA is the only clinically validated solution that detects and quantifies cerebral microbleeds and superficial siderosis on both T2GRE and SWI scans. Coupled with FLAIR lesion quantification of cerebral edema, NeuroQuant for ARIA offers a complete solution for AI-assisted monitoring of Alzheimer’s disease patients on anti-amyloid immunotherapies.

Dr. Ana Franceschi, a nationally recognized authority in dementia imaging and molecular neuroimaging and a member of both the Cortechs.ai Medical Advisory Board and ALZ-NET’s Imaging Work Group, expressed strong support for the initiative:

“It is a privilege to serve on Cortechs.ai’s Medical Advisory Board as we embark on this important collaboration with ALZ-NET. Combining advanced neuroimaging analytics with real-world data is a critical step in optimizing safety and monitoring for Alzheimer’s patients receiving anti-amyloid therapies. This collaboration holds great promise for clinicians and patients alike.”

Sponsored by the Alzheimer’s Association and managed and operated by the American College of Radiology (ACR), ALZ-NET is a voluntary health care provider-enrolled network collecting real-world clinical and imaging data from patients evaluated for or treated with new FDA-approved Alzheimer’s therapies Through the collection of longitudinal, real-world data across a multi-site network, ALZ-NET aims to provide evidence-based critical insights into long-term safety and efficacy of Alzheimer’s therapies..

“Alzheimer’s disease is a prevalent and devastating condition that touches millions of families. Our collaboration with ALZ-NET represents a shared commitment to using data and technology to improve how we care for people with dementia,” says Kyle Frye, CEO of Cortechs.ai. “With NeuroQuant for ARIA, we’re giving clinicians the tools they need to make smarter, safer decisions, and by connecting with ALZ-NET’s powerful data network, we can collectively advance treatment practices for the entire field.”

Cortechs.ai is a leader in AI applications in radiology, leveraging advanced technologies in medical imaging to enhance disease screening and early detection, empowering healthcare providers to deliver better outcomes for patients.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!